Preview

РЕЦЕПЦИЯ СТЕРОИДНЫХ ГОРМОНОВ В НОРМАЛЬНОЙ И ОПУХОЛЕВОЙ ТКАНЯХ ЩИТОВИДНОЙ ЖЕЛЕЗЫ

https://doi.org/10.14341/ket20084310-17

Полный текст:

Об авторах

E V Zyrlina



A A Porosova



Список литературы

1. Берштейн Л.М. Гормональный канцерогенез. СПб.: Наука,.2000. 199 с.

2. Берштейн Л.М. Онкоэндокринология: традиции, современность и перспективы. СПб.: Наука, 2004. 343 с.

3. Берштейн Л.М. Рак щитовидной железы: эпидемиология, эндокринология, факторы и механизмы канцерогенеза // Практ. онкол. 2007. Т. 8. № 1. С. 1-8.

4. Валдина Е.А. Заболевания щитовидной железы: Руководство. 3-е изд. Спб.: Изд. дом “Питер”, 2006. 368 с.

5. Пачес А.И. Рак щитовидной железы // Опухоли головы и шеи. 4-е изд. М.: Медицина, 2000. С. 379-407.

6. Романчишин А.Ф. Клинико-патогенетические варианты новообразований щитовидной железы. СПб.: Наука.1992. 258 с.

7. Фадеев В.В., Мельниченко Г.А. Физиологические дозы йода и носительство антител к тиреоидной пероксидазе: Открытое рандомизированное исследование // Пробл. эндокринол. 2004. Т. 50. № 5. С. 3-7.

8. Arain S.A., Shah M.H., Meo S.A., Jamal Q. Estrogen receptors in human thyroid gland. An immunohistochemical study // Saudi Med. J. 2003. V. 24. N 2. Р 174-178.

9. Bléchet C., Lecomte P., De Calan L. et al. Expression of sex steroid hormone receptors in С cell hyperplasia and medullary thyroid carcinoma // Virchows Arch. 2007. V. 450. N 4. P. 433-439.

10. Bonacci R., Pinchera A., Fierabracci P. et al. Relevance of estrogen and progesterone receptors enzyme immunoassay in malignant, benign and surrounding normal thyroid tissue // J. Endocrinol. Invest. 1996. V. 19. N 3. P. 159-164.

11. Böttner M., Christoffel J., Rimoldi G., Wuttke W. Effects of long-term treatment with resveratrol and subcutaneous and oral estradiol administration on the pituitary-thyroid-axis // Exp. Qin. Endocrinol. Diabetes. 2006. V. 114. N 2. P. 82-90.

12. Bur M., Shiraki W., Masood S. Estrogen and progesterone receptor detection in neoplastic and non-neoplastic thyroid tissues // Mod. Pathol. 1993. V. 6. N 4. P. 469-472.

13. Candanedo-Gonzalez F.A., Camboa-dominguez A. Postmenopause is associated with recurrence of differentiated papillary thyroid carcinoma // Med. Hypotheses. 2007. V. 69. N 1. Р 209-213.

14. Ceresini G., Milli B., Morganti S. et al. Effect of estrogen therapy for 1 year on thyroid volume and thyroid nodules in postmenopausal women // Menopause. 2008. V. 15. N 2. P. 326-331.

15. Ceresini G., Morganti S., Graiani V. et al. Estrogen receptor (ER)-beta, but not ER-alpha, is present in thyroid vessels: immunohistochemical evaluations in multinodular goiter and papillary thyroid carcinoma // Thyroid. 2006. V. 16. N 12. P. 1215-1220.

16. Chan E.K., Sepkovic D.W., Yoo Bowne H.J. et al. A hormonal association between estrogen metabolism and proliferative thyroid disease // Otolaryngol. Head Neck Surg. 2006. V. 134. N 6. P. 893-900.

17. Chaudhuri P.K., Prinz R. Estrogen receptor in normal and neoplastic human thyroid tissue // Am. J. Otolaryngol. 1989. V. 10. N 5. P. 322-326.

18. Clark O.H., Gerend P.L., Davis M. et al. Estrogen and thyroid-stimulating hormone (TSH) receptors in neoplastic and nonneoplastic human thyroid tissue // J. Surg. Res. 1985. V. 38. N 2. P. 89-96.

19. Dalla Valle L., Ramina A., Vianello S. et al. Potential for Estrogen Synthesis and Action in Human Normal and Neoplastic Thyroid Tissues // J. Qin. Endocrinol. Metab. 1998. V. 83. N 10. P. 3702-3709.

20. Egawa C., Miyoshi Y., Iwao K. et al. Quantitative analysis of estrogen receptor-alpha and -beta messenger RNA expression in normal and malignant thyroid tissues by real-time polymerase chain reaction // Oncology. 2001. V. 61. N 4. P. 293-298.

21. Farahati J., Wegscheider Κ., Christ K. et al. Gender-specific determinants of goiter // Biol. Trace Elem. Res. 2006. V. 113. N 3. P. 223-230.

22. Fassina A., Rupolo M., Pelizzo M.R., Casara D. Thyroid cancer in children and adolescents // Tumori. 1994. V. 80. N 4. P. 257-262.

23. Furlanetto T.W., Nguyen and L.Q. Jameson L. Estradiol Increases Proliferation and Down-Regulates the Sodium/Iodide Symporter Gene in FRTL-5 Cells // Endocrinology. 1999. V. 140. N 12. P. 5705-5711.

24. Ginestier C., Hur M.H., Charafe-Jauffret E. et al. ALDH1 Is a Marker of Normal and Malignant Human Mammary Stem Cells and a Predictor of Poor Cinical Outcome. // Cell. Stem. Cell. 2007. V. 1. N 5. P. 555-567

25. Gougelet A., Mueller S.O., Korach K.S., Renoir J.M. Oestrogen receptors pathways to oestrogen responsive elements: the transactivation function-1 acts as the keystone of oestrogen receptor (ER)beta-mediated transcriptional repression of ERalpha // J. Steroid Biochem. Mol. Biol. 2007. V. 104. N 3-5. P. 110-122.

26. Greenman D.L., Highman B., Chen J. et al. Estrogen-induced thyroid follicular cell adenomas in C57BL/6 mice // J. Toxicol. Environ. Health. 1990. V. 29. N 3. P. 269-278.

27. Hiasa Y., Kitahori Y., Yane K. et al. Establishment of estrogen receptor-positive transplantable rat thyroid tumor cell lines in vivo // Cancer Res. 1993. V. 53. N 18. P. 4408-4412.

28. Hiasa Y., Nishioka H., Kitahori Y. et al. Immunohistochemical analysis of estrogen receptors in 313 paraffin section cases of human thyroid tissue // Oncology. 1993. V. 50. N 2. P. 132-136.

29. Hong G.S., Sng I.T., Soo K.C. Oestrogen receptors in well differentiated thyroid cancers // Ann. Acad. Med. Singapore. 1991. V. 20. N 6. P. 767-769.

30. Inoue H., Oshimo K., Miki H. et al. Immunohistochemical study of estrogen receptors and responsiveness to estrogen in papillary thyroid carcinoma // Cancer. 1993. V. 72. N 4. P. 1364-1368.

31. Jaklic B.R., Rushin J., Ghosh B.C. Estrogen and progesterone receptors in thyroid lesions // Ann. Surg. Oncol. 1995. V. 2. N 5. P. 429-434.

32. Kabat G.C., O’Leary E.S., Gammon M.D. et al. Estrogen metabolism and breast cancer // Epidemiology. 2006. V. 17. N 1. P. 80-88.

33. Kawabata W., Suzuki T., Moriya T. Estrogen Receptors (alpha and beta) and 17 beta-Hydroxysteroid Dehydrogenase Type 1 and 2 in Thyroid Disorders: Possible In Situ Estrogen Synthesis and Actions // Mod. Pathol. 2003. V. 16. N 5. P. 437-444.

34. Kesse-Adu R., Shousha S. Myoepithelial markers are expressed in at least 29% of oestrogen receptor negative invasive breast carcinoma // Mod. Pathol. 2004. V. 17. N 6. P. 646-652.

35. Lee S.H., Kim K.M., Jung B.H. et al. Estrogens in female thyroid cancer: alteration of urinary profiles in pre- and post-operative cases // Cancer Lett. 2003 V. 189. N 1. P. 27-32.

36. Lewy-Trenda I. Estrogen and progesterone receptors in neoplastic and non-neoplastic thyroid lesions // Pol. J. Pathol. 2002. V. 53. N 2. P. 67-72.

37. Maggiolini M., Vivacqua A., Fasanella G. Et al. The G protein-coupled receptor GPR30 mediates c-fos up-regulation by 17β-estradiol and phytoestrogens in breast cancer cells // J. Biol. Chem. 2004. V. 279. N 26. P. 27008-27016.

38. Manole D., Schildknecht B., Gosnell B. et al. Estrogen promotes growth of human thyroid tumor cells by different molecular mechanisms // J. Clin. Endocrinol. Metab. 2001. V. 86. N 3. P. 1072-1077.

39. Marugo M., Torre G., Bernasconi D. et al. Thyroid and steroid receptors // J. Endocrinol. Invest. 1989. V. 12. N 8. P. 565-570.

40. Mc Tiernan A.M., Weiss N.S. and Daling J.R. Incidence of thyroid cancer in women in relation to reproductive and hormonal factors // J. Epidemiol. 1984. V. 120. N 3. P. 423-435.

41. Memon G.R., Arain S.A., Jamal Q., Ansari T. Immunohistochemical study of progesterone receptors in thyroid gland // J. Pak. Med. Assoc. 2005. V. 55. N 8. P. 321-324.

42. Miki H., Oshimo K., Inoue H. et al. Sex hormone receptors in human thyroid tissues // Cancer. 1990. V. 66. N 8. P. 1759-1762.

43. Miller W.R., Shivas A.A., Forrest A.P. Steroid metabolism by human thyroid, nodular goitre, and thyroid cancer // Br. J. Cancer. 1974. V. 30. N 3. P. 284-287.

44. Mizukami Y., Michigishi T., Nonomura A. et al. Estrogen and estrogen receptors in thyroid carcinomas // J. Surg. Oncol. 1991. V. 47. N 3. P. 165-169.

45. Money S.R., Muss W., Thelmo W.L. et al. Immunocytochemical localization of estrogen and progesterone receptors in human thyroid // Surg. 1989. N 106. P 975-979.

46. Munroe D.G., Chang P.L. Tissue-specific expression of human arylsulfatase-С isozymes and steroid sulfatase // Am. J. Hum. Genet. 1987. V. 40. N 2. P. 102-114.

47. Nam K.H., Chung W.Y., Park C.S. et al. Expression and role of estrogen receptor alpha and beta in medullary thyroid carcinoma: different roles in cancer growth and apoptosis // J. Endocrinol. 2007. V. 195. N 2. P. 255-263.

48. Nardulli A.M., Greene G.L., O’Malley B.W., Katzenellenbogen B.S. Regulation of progesterone receptor messenger ribonucleic acid and protein levels in MCF-7 cells by estradiol: analysis of estrogen’s effect on progesterone receptor synthesis and degradation // Endocrinology. 1988. V. 122. N 3. P. 935-944.

49. Parmeggiani D., Malinconico F.A., Moccia G. et al. Hormonal therapy in oncologic treatment: pathogenic hypotheses and interactions between thyroid and breast pathologies // Tumori. 2003. V. 89. N 4. P. 215-219.

50. Souma J.A., Green P.J., Coppage A.T. et al. Changes in thyroid function in pregnancy and with oral contraceptive use // Souht Med. J. 1981. V. 74. N 6. P. 684-687.

51. Takagi H., Mitsumori K., Onodera H. et al. Improvement of a two-stage carcinogenesis model to detect modifying effects of endocrine disrupting chemicals on thyroid carcinogenesis in rats // Cancer Lett. 2002. V. 178. N 1. P. 1-9.

52. Takano T. Fetal cell carcinogenesis of the thyroid: a hypothesis for better understanding of gene expression profile and genomic alternation in thyroid carcinoma // Endocr. J. 2004. V. 51. N 6. P. 509-515.

53. Takeichi N., Ito H., Haruta R. et al. Relation between estrogen receptor and malignancy of thyroid cancer // Jpn. J. Cancer Res. 1991. V. 82. N 1. P. 19-22.

54. Takizawa T., Imai T., Ueda M. et al. Comparison of enhancing effects of different goitrogen treatments in combination with beta-estradiol-3-benzoate for establishing a rat two-stage thyroid carcinogenesis model to detect modifying effects of estrogenic compounds // Cancer Sci. 2006. V. 97. N 1. P. 25-31.

55. Tavangar S.M., Monajemzadeh M., Larijani B., Haghpanah V. Immunohistochemical study of oestrogen receptors in 351 human thyroid glands // Singapore Med. J. 2007. V. 48. N 8. P. 744-747.

56. Telang N.T., Suto A., Wong G.Y. et al. Induction by estrogen metabolite 16a-hydroxyestrone of genotoxic damage and aberrant proliferation in mouse mammary epithelial cells // J. Nat. Cancer Inst. 1992. V. 84. N 8. P. 634-638.

57. Thiruvengadam A., Govindarajulu P., Aruldhas M.M. Modulatory effect of estradiol and testosterone on the development of N-nitrosodiisopropanolamine induced thyroid tumors in female rats // Endocr. Res. 2003. V. 29. N 1. P. 43-51.

58. Ursin G., London S., Stanczyk F.Z. et al. Urinary 2-hydroxye-strone/16alpha-hydroxyestrone ratio and risk of breast cancer in postmenopausal women // J. Natl. Cancer Inst. 1999. V. 91. N 12. P. 1067-1072.

59. Van Hoeven K.H., Menendez-Botet C.J., Strong E.W., Huvos A.G. Estrogen and progestrone receptor content in human thyroid disease // Am. J. Clin. Pathol. 1993. V. 99. N 2. P. 175-181.

60. Van Staveren W.C., Solhs D.W., Delys L. at al. Human thyroid tumor cell lines derived from different tumor types present a common dedifferentiated phenotype // Cancer Res. 2007. V. 67. N 17. P. 8113-8120.

61. Vivacqua A., Bonofiglio D., Albanito L. et al. 17-Estradiol, Genistein, and 4-Hydroxytamoxifen Induce the Proliferation of Thyroid Cancer Cells through the G Protein-Coupled Receptor GPR30 // Mol. Pharmacol. 2006. V. 70. N 4. P. 1414-1423.

62. Vivacqua A., Bonofiglio D., Recchia A.G. et al. The G protein-coupled receptor GPR30 mediates the proliferative effects induced by beta-estradiol and hydroxytamoxifen in endometrial cancer cells // Mol. Endocrinol. 2006. N 20 P. 631-646.

63. Yamamoto M., Shirai M., Sugita K. et al. Effects of maternal exposure to diethylstilbestrol on the development of the reproductive system and thyroid function in male and female rat offspring // J. Toxicol. Sci. 2003. V. 28. N 5. P. 385-394.

64. Yane Κ., Kitahori Y., Konishi N. et al. Expression of the estrogen receptor in human thyroid neoplasms // Cancer Lett. 1994. V. 84. N 1. P. 59-66.

65. Zeng Q., Chen G.G., Vlantis A.C., van Hasselt C.A. Oestrogen mediates the growth of human thyroid carcinoma cells via an oestrogen receptor-ERK pathway // Cell Prolif. 2007. V. 40. N 6. P. 921-935.


Для цитирования:


Zyrlina E.V., Porosova A.A. РЕЦЕПЦИЯ СТЕРОИДНЫХ ГОРМОНОВ В НОРМАЛЬНОЙ И ОПУХОЛЕВОЙ ТКАНЯХ ЩИТОВИДНОЙ ЖЕЛЕЗЫ. Клиническая и экспериментальная тиреоидология. 2008;4(3):10-17. https://doi.org/10.14341/ket20084310-17

For citation:


., . Steroid Hormones Reception in Normal and Tumorous Thyroid Tissues. Clinical and experimental thyroidology. 2008;4(3):10-17. (In Russ.) https://doi.org/10.14341/ket20084310-17

Просмотров: 19


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 1995-5472 (Print)
ISSN 2310-3787 (Online)